RIGL
Rigel Pharmaceuticals
$37.39
+$0.65 (+1.77%)Jul 27, 2026
Key metrics
The numbers that frame RIGL today
- Market cap
- $691.79M
- P/E (TTM)
- 1.9
- EV / FCF
- 9.0
- Gross margin
- 93.4%
- EV / Sales
- 2.4
- ROIC
- 49%
- Div yield
- 0%
- Debt / equity
- 0.1
- 52wk Low
- $19.51
- 52wk High
- $52.24
Growth
Revenue and earnings trend for RIGL
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about RIGL
Is Rigel Pharmaceuticals a good buy?
Hold. Rigel Pharmaceuticals has mixed quality and excellent momentum. The setup is mixed. Growth looks poor. That could put pressure on the long-term business case. We think Rigel Pharmaceuticals is selling at a low price.
What is the market capitalization of RIGL?
Rigel Pharmaceuticals's market capitalization is $691.79M.
What is the P/E ratio for RIGL stock?
Rigel Pharmaceuticals's current P/E ratio is 1.9.
What is the 52-week high for RIGL stock?
The 52-week high for Rigel Pharmaceuticals is $52.24. The current close of $37.39 is 28.4% below that high.
What is the 52-week low for RIGL stock?
The 52-week low for Rigel Pharmaceuticals is $19.51. The current close of $37.39 is 91.6% above that low.
Does RIGL stock pay dividends?
Rigel Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for RIGL?
Rigel Pharmaceuticals's Debt / Equity ratio is 0.11.